Researchers have found that adults who stop taking GLP-1 receptor agonist drugs such as semaglutide and tirzepatide face a measurable increase in heart attack, stroke, and death risk within months of ...

Objective To evaluate the safety and durability of telitacicept treatment in patients with SLE by identifying the reasons for ...

Wrapping dehydrated human amniotic membrane around nerve and anastomotic tissue during robotic prostatectomy was associated ...

A real-world analysis of patients receiving teclistamab prior to 2022 showed comparable outcomes to clinical trials and ...

Exposure to secondhand smoke is linked to many adverse pediatric health outcomes. Well-child visits can be an opportunity to ...

We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of readily accessible and low-cost ...

A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of ...

Dr Ray O’Connor takes a look at the latest clinical studies on dementia, including its diagnosis and management ...

For patients with obesity and atrial fibrillation (Afib), GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested.

Data are early, retrospective, and unlikely to influence guidelines, but interest among operators is growing, says Sameh Sayfo.

Background: The factors involved in the association between obstetric trauma and the race of the birthing parent are uncertain. We sought to assess the association between race and obstetric trauma, ...

In this large international cohort of immunocompromised patients with ARF, we identified key risk and protective factors for mortality and intubation. These findings could improve outcomes by ...